|
Volumn 34, Issue 12, 2001, Pages 1551-1559
|
Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: A multicenter study
a a a a a a a a |
Author keywords
Cancer; Chemotherapy; Fetal outcome; Pregnancy; Teratogenicity
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
BLEOMYCIN;
BUSULFAN;
CHLORMETHINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DACARBAZINE;
DAUNORUBICIN;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
HYDROXYUREA;
IDARUBICIN;
METHOTREXATE;
PREDNISONE;
PROCARBAZINE;
VINBLASTINE;
VINCRISTINE;
ADOLESCENT;
ADULT;
ARTICLE;
BENIGN TUMOR;
BRAZIL;
CANCER CHEMOTHERAPY;
COHORT ANALYSIS;
CONTROLLED STUDY;
EVALUATION;
FEMALE;
FETUS;
FETUS MALFORMATION;
FETUS MORTALITY;
FETUS RISK;
FIRST TRIMESTER PREGNANCY;
FISHER EXACT TEST;
FOLLOW UP;
GESTATION PERIOD;
HUMAN;
LONG TERM CARE;
MEDICAL RECORD;
MULTICENTER STUDY;
OUTCOMES RESEARCH;
PREMATURITY;
PRENATAL DRUG EXPOSURE;
QUANTITATIVE ANALYSIS;
RANK SUM TEST;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
MARTES PENNANTI;
|
EID: 0035746242
PISSN: 0100879X
EISSN: 1414431X
Source Type: Journal
DOI: 10.1590/S0100-879X2001001200007 Document Type: Article |
Times cited : (65)
|
References (26)
|